2019
DOI: 10.1073/pnas.1819473116
|View full text |Cite
|
Sign up to set email alerts
|

Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1

Abstract: The combination of immune checkpoint blockade with chemotherapy is currently under investigation as a promising strategy for the treatment of triple negative breast cancer (TNBC). Tumor-associated macrophages (TAMs) are the most prominent component of the breast cancer microenvironment because they influence tumor progression and the response to therapies. Here we show that macrophages acquire an immunosuppressive phenotype and increase the expression of programmed death ligand-1 (PD-L1) when treated with reac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
103
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 152 publications
(105 citation statements)
references
References 62 publications
2
103
0
Order By: Relevance
“…However, the transient oxidative stress can generate ligands that activate anti-inflammatory signaling systems such as Peroxisome Proliferator-Activated Receptor-gamma (PPARγ) and Liver X-Receptor-alpha (LXRα) in monocyte-macrophages during training [ 63 ]. In addition, ROS modulate macrophages’ immunosuppressive phenotype through the up-regulation of programmed death-ligand 1 (PD-L1) [ 64 ]. Thus, more ROS production at the beginning of the race training may enhance the creation of the anti-inflammatory state.…”
Section: Discussionmentioning
confidence: 99%
“…However, the transient oxidative stress can generate ligands that activate anti-inflammatory signaling systems such as Peroxisome Proliferator-Activated Receptor-gamma (PPARγ) and Liver X-Receptor-alpha (LXRα) in monocyte-macrophages during training [ 63 ]. In addition, ROS modulate macrophages’ immunosuppressive phenotype through the up-regulation of programmed death-ligand 1 (PD-L1) [ 64 ]. Thus, more ROS production at the beginning of the race training may enhance the creation of the anti-inflammatory state.…”
Section: Discussionmentioning
confidence: 99%
“…IHC analysis of clinical specimens confirmed the positive correlation of NOX4 and CD68 or CD206 [253]. ROS accumulation in BMDMs that was reached by ROS inducer, glutathione synthesis inhibitor buthionine sulphoximine (BSO), results in increased expression of programmed death ligand-1 (PD-L1) and production of IL-10, IL-17, IL-4, IL-1b, insulin-like growth factor-binding protein 3 (IGFBP-3), and chemokine (C-X-C motif) ligand 1 (CXCL1) that are associated with an immune-suppressive phenotype of macrophages [271].…”
Section: Role Of Hypoxiamentioning
confidence: 99%
“…Hence, inhibition of TAM-derived angiogenesis-inducing factors potentially improve the efficacy of chemotherapy [119,120]. Recent study, regarding immune checkpoint blockad with chemotherapy in TNBC patients, reactive oxygen species (ROS) and oxidative stress induced by taxane in macrophages render them immunosuppressive and expressing PD-L1 [121].…”
Section: Induction Of Treatment Resistance By Tamsmentioning
confidence: 99%